Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Brownsville › NPI 1174576714
Physician

Lecusay, David

Lecusay, David was paid $214K by Medicaid between Feb 2018 and Mar 2024, across 36 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.

33Billing provider infoLECUSAY, DAVID
BROWNSVILLE, TX 78520
33aNPI1174576714assigned 05/17/2006
33bProvider typePediatrics Physician
28Total paid$214K
24GClaims12,714
24DCodes billed36
24AFirst – last monthFeb 2018 – Mar 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#626 of 1,136
Median peer was paid$329K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018246$5K
2019227$4K
20202,662$37K
20219,419$163K
202295$3K
202352$2K
2024incomplete13$518.70
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 26% 3,991 3,479 $55K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 15% 423 419 $33K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 13% 358 357 $27K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 12% 346 329 $26K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 7.5% 398 386 $16K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 7.1% 202 201 $15K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 6.2% 336 325 $13K
90460 Immunization administration through 18 years of age via any route, first or only component 5.0% 1,449 1,331 $11K
99429 1.7% 149 147 $4K
90461 1.0% 629 524 $2K
0001A <1% 52 47 $2K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 275 216 $2K
24 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 454 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 339 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 134 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 112 $1K
83655 <1% 174 $1K
99000 <1% 259 $646.88
96160 <1% 218 $410.46
87807 <1% 29 $266.28
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 15 $245.40
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 34 $13.19
86580 <1% 46 $12.92
36415 Collection of venous blood by venipuncture 0% 434 $0.00
90688 0% 462 $0.00
90651 0% 30 $0.00
G9273 Blood pressure has a systolic value of < 140 and a diastolic value of < 90 0% 762 $0.00
90698 0% 24 $0.00
90680 0% 89 $0.00
D1208 Topical application of fluoride, excluding varnish 0% 147 $0.00
90723 0% 12 $0.00
90696 0% 13 $0.00
90670 0% 225 $0.00
91300 0% 52 $0.00
90710 0% 14 $0.00
90648 0% 28 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.